Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Stock Short Interest Report for September

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) saw a large drop in short interest in September. As of September 30th, there was short interest totaling 55,588 shares, a drop of 63.4% from the September 15th total of 151,789 shares. Based on an average daily trading volume, of 188,910 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company’s shares are sold short.

Sernova Biotherapeutics Price Performance

SEOVF stock traded down $0.00 during mid-day trading on Tuesday, reaching $0.08. The company had a trading volume of 10,101 shares, compared to its average volume of 58,096. The company has a market capitalization of $29.46 million, a PE ratio of -1.95 and a beta of 0.89. The firm has a 50 day moving average of $0.08 and a 200 day moving average of $0.10. Sernova Biotherapeutics has a 12 month low of $0.06 and a 12 month high of $0.14.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings results on Thursday, September 10th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01).

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies designed to provide long-term treatment for chronic diseases. The company’s primary platform, the Cell Pouch System, is an implantable device intended to create a vascularized environment in the body where therapeutic cells can be placed and supported.

Sernova has focused on cell-based therapies for conditions including type 1 diabetes, hemophilia A and thyroid disease. Its approach combines the Cell Pouch System with insulin-producing islet cells, blood-clotting factor-producing cells or other therapeutic cells, with the goal of restoring biological functions that are impaired by disease.